MDxHealth S.A. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,105.10
11,566.30
12,969.40
11,612.80
10,881.80
27,207.50
Depreciation, Depletion & Amortization
314.90
251.00
794.50
1,554.90
1,672.10
2,489.50
Other Funds
286.20
339.30
401.30
609.30
801.50
437.40
Funds from Operations
11,504.10
10,976.00
11,773.60
9,448.60
8,408.30
24,280.60
Changes in Working Capital
885.80
2,970.30
1,194.90
5,539.70
891.00
246.70
Net Operating Cash Flow
10,618.30
13,946.30
12,968.50
14,988.30
9,299.30
24,527.20
Capital Expenditures
916.70
1,011.70
1,894.60
4,416.00
4,308.80
Purchase/Sale of Investments
52.70
-
-
-
-
Net Investing Cash Flow
948.30
957.40
6,843.60
4,810.20
5,366.40
Issuance/Reduction of Debt, Net
-
-
208.30
72.30
306.80
Net Financing Cash Flow
18,288.40
11,056.60
31,600.10
19,069.80
508.00
Net Change in Cash
6,950.80
4,362.00
11,527.40
731.30
12,451.10
Free Cash Flow
10,811.80
14,145.30
14,390.60
15,992.60
10,338.40
Net Assets from Acquisitions
-
-
4,859.70
-
979.70
Other Sources
-
54.30
-
-
-
Change in Capital Stock
18,288.40
11,056.60
31,391.80
18,997.50
201.30
Exchange Rate Effect
229.00
514.90
260.60
2.70
1,706.70
Other Uses
84.40
-
89.30
394.10
78.00

About MDxHealth

View Profile
Address
CAP Business Center
Herstal WA 4040
Belgium
Employees -
Website http://www.mdxhealth.com
Updated 07/08/2019
MDxHealth SA is a molecular diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S.